Maynard Um
-
-
-
-
-
-
-
Benitec's (BNTC) Capital Raise Provides Support For Regulatory Filing - Citizens
-
-
-
-
-
-
-
Benitec Biopharma gets safety board approval to advance BB-301 trial
-
-
-
-
-
-
-
Benitec Biopharma (BNTC) Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Benitec BioPharma (BNTC)
-
-
-
-
-
-
-
Here's the list of biotech stocks that have key data catalysts in 2025
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

